Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways-Reference-Cited by-同舟云学术

Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways

Published:2018-11-21 Issue:8 Volume:58 Page:3207-3219
ISSN:1436-6207
Container-title:European Journal of Nutrition
language:en
Short-container-title:Eur J Nutr

Author:

Cruz-Lozano Marina,González-González Adrián,Marchal Juan A.,Muñoz-Muela Esperanza,Molina Maria P.,Cara Francisca E.,Brown Anthony M.,García-Rivas Gerardo,Hernández-Brenes Carmen,Lorente Jose A.,Sanchez-Rovira Pedro,Chang Jenny C.,Granados-Principal Sergio^ORCID

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s00394-018-1864-1.pdf

Reference62 articles.

1. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363:1938–1948. https://doi.org/10.1056/NEJMra1001389

2. González-González A, Muñoz-Muela E, Marchal JA et al (2018) Activating transcription factor 4 modulates TGFβ-induced aggressiveness in triple negative breast cancer via SMAD2/3/4 and mTORC2 signaling. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-17-3125

3. Lehmann BD, Bauer JA, Chen X et al (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest 121:2750–2767. https://doi.org/10.1172/JCI45014